Nascent Biotech Competitors and Similar CompaniesClear all
Nascent Biotech's competitors and similar companies include Gamida Cell and Innate Pharma.
 Gamida Cell Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases. |  Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | ||
Founding Date | Founding Date 2014 | Founding Date 1998 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Boston, US HQ Jerusalem, IL | Locations Marseille, FR HQ Rockville, US |
Employees | Employees N/A | Employees 143175% increase | Employees 181 |
Valuation ($) | Valuation ($) 13.8 m | Valuation ($) 4.3 m | Valuation ($) 148.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.8m (FY, 2023) | Revenue (est.) €2.8m (FY, 2025) |
Cost of goods | Cost of goods $319.5k (FY, 2024) | Cost of goods $1.5m (FY, 2023) | Cost of goods €266k (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $330k (FY, 2023) | Gross profit €8.7m (FY, 2025) |
Net income | Net income ($2.1m) (FY, 2024) | Net income ($63m) (FY, 2023) | Net income (€49.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 2m | Total funding raised $ 128.3m | Total funding raised $ 94.1m |
For sources of this data, please see the company profile
View Company Profiles
Gamida Cell
HQ
Boston, US
Employees
143
Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases.
View companyInnate Pharma
HQ
Marseille, FR
Employees
181
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company